Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

DIFFERENTIAL MECHANISM-BASED INHIBITION OF CYP3A4 AND CYP3A5 BY VERAPAMIL

Ying-Hong Wang, David R. Jones and Stephen D. Hall
Drug Metabolism and Disposition May 2005, 33 (5) 664-671; DOI: https://doi.org/10.1124/dmd.104.001834
Ying-Hong Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen D. Hall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 5 664-671
DOI 
https://doi.org/10.1124/dmd.104.001834
PubMed 
15689501

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 11, 2004
  • Accepted January 26, 2005
  • Published online April 13, 2005.

Article Versions

  • Earlier version (February 2, 2005 - 11:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ying-Hong Wang,
  2. David R. Jones and
  3. Stephen D. Hall
  1. Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
  1. Address correspondence to:
    Dr. Stephen D. Hall, Indiana University School of Medicine, Division of Clinical Pharmacology, 1001 West 10th St., W7123, Indianapolis, IN 46202. E-mail: sdhall{at}iupui.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2005 to January 2021

AbstractFullPdf
Feb 2005790161
Mar 200564091
Apr 200514868221
May 200556100160
Jun 2005295976
Jul 2005335949
Aug 2005116054
Sep 2005144941
Oct 2005226242
Nov 2005184126
Dec 200562631
Jan 2006111827
Feb 2006183229
Mar 2006192014
Apr 2006142623
May 2006115651
Jun 2006203543
Jul 2006174339
Aug 2006145143
Sep 2006164249
Oct 200695666
Nov 2006163747
Dec 2006103932
Jan 200773651
Feb 2007103951
Mar 2007134377
Apr 2007185462
May 2007103864
Jun 2007103848
Jul 200764051
Aug 200753351
Sep 200782340
Oct 2007122354
Nov 200743165
Dec 200733158
Jan 200871243
Feb 200883256
Mar 200852854
Apr 200841840
May 2008183056
Jun 2008112960
Jul 2008142544
Aug 2008182431
Sep 2008122142
Oct 2008212250
Nov 2008202649
Dec 200852630
Jan 2009103140
Feb 2009193343
Mar 2009113032
Apr 2009223343
May 200982538
Jun 200982731
Jul 200992426
Aug 2009193031
Sep 2009212443
Oct 2009342439
Nov 2009192327
Dec 2009271731
Jan 2010161824
Feb 2010201812
Mar 2010263237
Apr 2010163623
May 2010131622
Jun 2010222317
Jul 2010312819
Aug 2010153628
Sep 2010123314
Oct 2010182119
Nov 201084330
Dec 2010112318
Jan 2011113824
Feb 2011131916
Mar 2011113517
Apr 201182128
May 2011162335
Jun 2011172344
Jul 2011273441
Aug 2011152424
Sep 2011343629
Oct 2011253630
Nov 2011382030
Dec 2011282825
Jan 2012163133
Feb 2012293330
Mar 2012303887
Apr 2012203599
May 20124359192
Jun 2012393728
Jul 2012134553
Aug 2012173895
Sep 20121839155
Oct 20124537173
Nov 2012273154
Dec 2012271730
Jan 2013263333
Feb 2013434430
Mar 2013353822
Apr 2013354629
May 2013353436
Jun 2013232216
Jul 2013271922
Aug 201382021
Sep 2013281937
Oct 2013292217
Nov 2013292020
Dec 2013162414
Jan 2014162617
Feb 2014161335
Mar 2014162325
Apr 2014192530
May 201452110
Jun 2014111512
Jul 20149268
Aug 2014302513
Sep 201482415
Oct 2014162717
Nov 2014132718
Dec 2014162915
Jan 2015151413
Feb 2015102818
Mar 2015194721
Apr 2015152210
May 2015152414
Jun 2015163017
Jul 2015212915
Aug 201592819
Sep 2015171912
Oct 2015192213
Nov 2015111312
Dec 201515138
Jan 2016231020
Feb 2016112217
Mar 2016191627
Apr 201671210
May 201691411
Jun 2016142720
Jul 2016102226
Aug 201691813
Sep 2016111014
Oct 20167299
Nov 201634222
Dec 20164209
Jan 201743020
Feb 20172169
Mar 201772814
Apr 20173164
May 201711910
Jun 201731717
Jul 201713418
Aug 201724114
Sep 201744417
Oct 201734316
Nov 201734112
Dec 20175268
Jan 201803111
Feb 201824413
Mar 2018128421
Apr 2018016119
May 2018113219
Jun 2018113220
Jul 201808020
Aug 201802512
Sep 20181308
Oct 201806514
Nov 2018111924
Dec 201863176
Jan 20197537
Feb 20196616
Mar 20194205
Apr 2019501312
May 20192014
Jun 20191048
Jul 20191523
Aug 20192344
Sep 20192922
Oct 20193017
Nov 20191833
Dec 20193469
Jan 20203477
Feb 20202643
Mar 2020972
Apr 20202011
May 20203612
Jun 20201533
Jul 20202135
Aug 20203127
Sep 20202875
Oct 20202864
Nov 20202865
Dec 20202455
Jan 202121164

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (5)
Drug Metabolism and Disposition
Vol. 33, Issue 5
1 May 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DIFFERENTIAL MECHANISM-BASED INHIBITION OF CYP3A4 AND CYP3A5 BY VERAPAMIL
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

DIFFERENTIAL MECHANISM-BASED INHIBITION OF CYP3A4 AND CYP3A5 BY VERAPAMIL

Ying-Hong Wang, David R. Jones and Stephen D. Hall
Drug Metabolism and Disposition May 1, 2005, 33 (5) 664-671; DOI: https://doi.org/10.1124/dmd.104.001834

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

DIFFERENTIAL MECHANISM-BASED INHIBITION OF CYP3A4 AND CYP3A5 BY VERAPAMIL

Ying-Hong Wang, David R. Jones and Stephen D. Hall
Drug Metabolism and Disposition May 1, 2005, 33 (5) 664-671; DOI: https://doi.org/10.1124/dmd.104.001834
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics